Antiarrhythmic drug development: Historical review and future perspective
- 1 January 2002
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 55 (1) , 3-16
Abstract
Cardiac ion channels represent the traditional target for antiarrhythmic drug development. Although channel‐selective drugs are effective in treating supraventricular arrhythmias, they are less effective against life‐threatening ventricular arrhythmias, and some are proarrhythmic. Paradoxically, the one exception, amiodarone, which uniquely suppresses ventricular fibrillation without proarrhythmia, is one of the least channel‐selective drugs currently available (and thus has extracardiac side effects). Thus, antiarrhythmic drug development has become becalmed. This review describes the history of antiarrhythmic drug development, considers antiarrhythmic drugs to date, and provides an overview of current novel therapeutic areas of drug development in an attempt to introduce some of the articles contained within this focused issue of Drug Development Research. Models (for preclinical antiarrhythmic drug assessment) and mechanisms (of drug action and arrhythmia suppression) are the themes of this issue. Drug Dev. Res. 55:3–16, 2002.Keywords
This publication has 96 references indexed in Scilit:
- Can Antiarrhythmic Agents be Selected Based on Mechanism of Action?Drugs, 2000
- Risks and Benefits of Antiarrhythmic TherapyNew England Journal of Medicine, 1994
- Antiarrhythmic Drug ClassificationsDrugs, 1991
- Significance of Classifying Antiarrhythmic Actions Since the Cardiac Arrhythmia Suppression TrialThe Journal of Clinical Pharmacology, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Recent Advances in Understanding the Pharmacology of AmiodaroneDrugs, 1988
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Amiodarone: Historical development and pharmacologic profileAmerican Heart Journal, 1983
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982
- The Efficacy of Antiarrhythmic Agents During Acute Myocardial Ischemia and the Role of Heart RateCirculation, 1974